These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 26340622)

  • 1. Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.
    Owaga E; Hsieh RH; Mugendi B; Masuku S; Shih CK; Chang JS
    Int J Mol Sci; 2015 Sep; 16(9):20841-58. PubMed ID: 26340622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease.
    Cătană CS; Berindan Neagoe I; Cozma V; Magdaş C; Tăbăran F; Dumitraşcu DL
    World J Gastroenterol; 2015 May; 21(19):5823-30. PubMed ID: 26019446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of probiotics and gut microbiota on Th17 cells.
    Tanabe S
    Int Rev Immunol; 2013; 32(5-6):511-25. PubMed ID: 24094077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad.
    Troncone E; Marafini I; Pallone F; Monteleone G
    Int Rev Immunol; 2013; 32(5-6):526-33. PubMed ID: 24041379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Th17 cell population and the immune homeostasis of the gastrointestinal tract.
    Rossi M; Bot A
    Int Rev Immunol; 2013; 32(5-6):471-4. PubMed ID: 24164337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Function and Role of the Th17/Treg Cell Balance in Inflammatory Bowel Disease.
    Yan JB; Luo MM; Chen ZY; He BH
    J Immunol Res; 2020; 2020():8813558. PubMed ID: 33381606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th17 Cells in Inflammatory Bowel Disease: Cytokines, Plasticity, and Therapies.
    Zhao J; Lu Q; Liu Y; Shi Z; Hu L; Zeng Z; Tu Y; Xiao Z; Xu Q
    J Immunol Res; 2021; 2021():8816041. PubMed ID: 33553436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.
    Plaza-Diaz J; Gomez-Llorente C; Fontana L; Gil A
    World J Gastroenterol; 2014 Nov; 20(42):15632-49. PubMed ID: 25400447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.
    Latella G; Fiocchi C; Caprili R
    J Crohns Colitis; 2010 Dec; 4(6):690-702. PubMed ID: 21122584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopathogenesis of IBD: Batf as a Key Driver of Disease Activity.
    Hildner K; Punkenburg E; Abendroth B; Neurath MF
    Dig Dis; 2016; 34 Suppl 1():40-7. PubMed ID: 27548324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid.
    Rafa H; Saoula H; Belkhelfa M; Medjeber O; Soufli I; Toumi R; de Launoit Y; Moralès O; Nakmouche M; Delhem N; Touil-Boukoffa C
    J Interferon Cytokine Res; 2013 Jul; 33(7):355-68. PubMed ID: 23472658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.
    Vanderpool C; Yan F; Polk DB
    Inflamm Bowel Dis; 2008 Nov; 14(11):1585-96. PubMed ID: 18623173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for probiotic treatment strategies in inflammatory bowel disease.
    Schultz M; Lindström AL
    Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):337-55. PubMed ID: 19072384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
    Hedin C; Whelan K; Lindsay JO
    Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics: The scientific evidence in the context of inflammatory bowel disease.
    Celiberto LS; Bedani R; Rossi EA; Cavallini DC
    Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1759-1768. PubMed ID: 25996176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
    Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A
    Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The therapeutic impact of manipulating microbiota in inflammatory bowel disease.
    Kanauchi O; Mitsuyama K; Andoh A
    Curr Pharm Des; 2009; 15(18):2074-86. PubMed ID: 19519445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Exclusive Enteral Nutrition on Th17 Cells in Juvenile Rats with Inflammatory Bowel Disease.
    Teng X; Qi Y; Li J; Wu J
    Inflammation; 2021 Feb; 44(1):261-269. PubMed ID: 32897457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding why probiotic therapies can be effective in treating IBD.
    Fedorak RN
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Probiotics for inflammatory bowel disease].
    Iizuka H; Takaishi H; Hibi T
    Nihon Rinsho; 2005 May; 63(5):776-80. PubMed ID: 15881169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.